AI Article Synopsis

  • This study aimed to evaluate the impact of Xiaoliu Baofei Pill (XBP) combined with chemotherapy on the quality of life (QOL) of patients with stage III-IV non-small cell lung cancer (NSCLC).
  • A total of 40 NSCLC patients were randomly divided into two groups: one received XBP plus chemotherapy, while the other received chemotherapy alone, with QOL assessed using the FACT-L tool.
  • Results showed that the treated group maintained more stable physical health and improved mood and function over time, while the control group's QOL declined, indicating that XBP combined with chemotherapy effectively enhances the overall quality of life in these patients.

Article Abstract

Objective: To objectively assess the influence of Xiaoliu Baofei Pill (XBP) combined with chemotherapy on quality of life (QOL) of patients with stage III-IV non-small cell lung cancer (NSCLC).

Methods: Forty NSCLC patients were equally randomized into 2 groups, the treated group treated with XBP plus chemotherapy, and the control group treated with chemotherapy alone. Patients' QOL was assessed by Functional Assessment of Cancer Therapy (FACT-L) before and after treatment.

Results: The scores of the physical condition in the treated group was relatively stable while it lowered significantly as time went by in the control group, significant difference was shown as compared with before treatment and with that in the treated group at the same time points (P < 0.05); scores of the mood condition, the function conditions and additional concerned condition were improved gradually from the 3rd collection in the treated group, but decreased in the control group, although some improvement of mood and function conditions had revealed temporarily in the early stage of treatment. Comparison between groups showed significant difference (P < 0.05). Besides, no significant change was found in domains of patient-doctor relation and society/family condition in both groups.

Conclusion: XBP combined with chemotherapy can obviously improve the QOL of advanced NSCLC patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

treated group
16
combined chemotherapy
12
control group
12
baofei pill
8
chemotherapy quality
8
quality life
8
non-small cell
8
cell lung
8
xbp combined
8
nsclc patients
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!